Impact of Virtual Care on Outpatient Urinary Tract Infection Management.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 30 01 2023
revised: 17 08 2023
accepted: 23 08 2023
medline: 11 12 2023
pubmed: 15 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

To examine the effect of virtual care on urine testing, antibiotic prescription patterns, and outcomes of care in urinary tract infection (UTI) management. We conducted retrospective analysis of adults treated for UTI in an ambulatory setting across a large health system from March 2020-2021. Outcomes included urine testing, antibiotic prescription, and retreatment or hospitalization, stratified by in-person vs virtual visit. Multivariable logistic regression was performed to examine factors contributing to outcomes. Significantly fewer patients seen virtually had urine testing as compared to those seen in-person (19% vs 69%, P <.001). On multivariable logistic regression analysis, virtual visit was the most significant predictor of urine testing, associated with an 86% reduction in the odds of urine testing (odds ratio (OR) 0.14, P <.001). Having a complicated UTI did not affect the likelihood of urine testing (OR 1.0, P = .95). Patients seen virtually were more likely to have a subsequent repeat ambulatory UTI visit (OR 1.16) or repeat antibiotic prescription (1.06) more than 2 weeks after the index encounter, though no more likely to be hospitalized for UTI (OR 1.00). Virtual care for UTI is associated with a significant reduction in urine testing and an increase in repeat UTI encounters and additional antibiotics among patients with complicated and uncomplicated UTIs.

Identifiants

pubmed: 37708981
pii: S0090-4295(23)00747-1
doi: 10.1016/j.urology.2023.08.028
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-47

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest SPE: consultant and speaker for Boston Scientific, PI of clinical trial and consultant for urotronic, investment interest for percuvision. The other authors report no conflict of interest.

Auteurs

Molly E DeWitt-Foy (ME)

Cleveland Clinic Foundation, Glickman Urological and Kidney Institute, Department of Urology, Cleveland, OH. Electronic address: dewittm2@ccf.org.

Jacob Albersheim (J)

University of Minnesota, Department of Urology, Minneapolis, MN.

Shawn Grove (S)

University of Minnesota, Department of Urology, Minneapolis, MN.

Lina Hamid (L)

University of Minnesota, Infectious Diseases and Antimicrobial Stewardship Clinical Pharmacy, Minneapolis, MN.

Sally Berryman (S)

University of Minnesota, Department of Internal Medicine, Minneapolis, MN.

Rebecca Freese (R)

University of Minnesota Clinical and Translational Science Institute, Minneapolis, MN.

Sean P Elliott (SP)

University of Minnesota, Department of Urology, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH